These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 34937342)

  • 21. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
    Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J
    Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
    Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
    Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
    Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
    J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.
    Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M
    Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HLA system, antigen processing and presentation.
    Krensky AM
    Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins.
    Harris PE; Maffei A; Colovai AI; Kinne J; Tugulea S; Suciu-Foca N
    Blood; 1996 Jun; 87(12):5104-12. PubMed ID: 8652823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules.
    Mustafa AS; Shaban FA; Al-Attiyah R; Abal AT; El-Shamy AM; Andersen P; Oftung F
    Scand J Immunol; 2003 Feb; 57(2):125-34. PubMed ID: 12588658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
    Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
    Front Immunol; 2019; 10():687. PubMed ID: 31001281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules.
    Chiari R; Hames G; Stroobant V; Texier C; Maillère B; Boon T; Coulie PG
    Cancer Res; 2000 Sep; 60(17):4855-63. PubMed ID: 10987298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors.
    Marcu A; Schlosser A; Keupp A; Trautwein N; Johann P; Wölfl M; Lager J; Monoranu CM; Walz JS; Henkel LM; Krauß J; Ebinger M; Schuhmann M; Thomale UW; Pietsch T; Klinker E; Schlegel PG; Oyen F; Reisner Y; Rammensee HG; Eyrich M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.
    Nisini R; Paroli M; Accapezzato D; Bonino F; Rosina F; Santantonio T; Sallusto F; Amoroso A; Houghton M; Barnaba V
    J Virol; 1997 Mar; 71(3):2241-51. PubMed ID: 9032359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.
    Lisowska-Grospierre B; Charron DJ; de Préval C; Durandy A; Griscelli C; Mach B
    J Clin Invest; 1985 Jul; 76(1):381-5. PubMed ID: 3860509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
    Robbins PF; El-Gamil M; Li YF; Zeng G; Dudley M; Rosenberg SA
    J Immunol; 2002 Nov; 169(10):6036-47. PubMed ID: 12421991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse
    Noe AR; Terry FE; Schanen BC; Sassano E; Hindocha P; Phares TW; Moise L; Christen JM; Tucker KD; Kotraiah V; Drake DR; Martin WD; De Groot AS; Gutierrez GM
    Front Immunol; 2021; 12():689920. PubMed ID: 34168657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
    Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
    J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
    Hershberg RM; Framson PE; Cho DH; Lee LY; Kovats S; Beitz J; Blum JS; Nepom GT
    J Clin Invest; 1997 Jul; 100(1):204-15. PubMed ID: 9202073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evidence that peptide vaccination can induce HLA-DR-restricted CD4+ T cells reactive to a class I tumor peptide.
    Harada M; Gohara R; Matsueda S; Muto A; Oda T; Iwamoto Y; Itoh K
    J Immunol; 2004 Feb; 172(4):2659-67. PubMed ID: 14764741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.
    God JM; Zhao D; Cameron CA; Amria S; Bethard JR; Haque A
    Immunology; 2014 Jul; 142(3):492-505. PubMed ID: 24628049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.